ITZHAK A. ROSNER

7.3k citations
221 papers · 5.8k · 1 hit paper · h-index 41

Impact in

  • Rheumatology top 0.2%
    • Rheumatoid Arthritis Research and Therapies
    • Systemic Lupus Erythematosus Research
    • Spondyloarthritis Studies and Treatments
  • Hepatology top 2%
    • Hepatitis C virus research

Papers in

    • Systemic Lupus Erythematosus Research 24
    • Spondyloarthritis Studies and Treatments 24
    • Rheumatoid Arthritis Research and Therapies 22

ITZHAK A. ROSNER

216 papers receiving 5.4k citations

ITZHAK A. ROSNER's Hit Papers

Efficacy and safety of tofacitinib monotherapy, tofacitinib with methotrexate, and adalimumab with methotrexate in patients with rheumatoid arthritis (ORAL Strategy): a phase 3b/4, double-blind, head-to-head, randomised controlled trial 2017 · 412 citations
4120+3+6Years since publication100200300400

Peers

ITZHAK A. ROSNER
Comparison fields: 5 of 136
  • Rheumatology 2.0k
  • Hepatology 337
  • Immunology 824
  • Dermatology 328
  • Hematology 407
Replace Alexandros A. Drosos with:
Alexandros A. Drosos Greece
Christian Beyer Germany
Antonella Afeltra Italy
Martina Fabris Italy
Henri André Ménard Canada
Giovanni Lapadula Italy
Shaye Kivity Israel
Johan Rönnelid Sweden
Shigeki Momohara Japan
JAN ANTHONIE BRUIJN Netherlands
ITZHAK A. ROSNER relative to Alexandros A. Drosos Greece Alexandros A. Drosos's profile →
Citations per field
00.5×2×2.7×
Alexandros A. Drosos · 1×
Citations per year

Countries citing papers authored by ITZHAK A. ROSNER

Since Specialization
Citations

This map shows the geographic impact of ITZHAK A. ROSNER's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by ITZHAK A. ROSNER with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites ITZHAK A. ROSNER more than expected).

Fields of papers citing papers by ITZHAK A. ROSNER

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by ITZHAK A. ROSNER. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by ITZHAK A. ROSNER. The network helps show where ITZHAK A. ROSNER may publish in the future.

Co-authors

The 25 scholars most cited alongside ITZHAK A. ROSNER, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with ITZHAK A. ROSNER Line = papers co-authored together ITZHAK A. ROSNER links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 221 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Efficacy and safety of tofacitinib monotherapy, tofacitinib with methotrexate, and adalimumab with methotrexate in patients with rheumatoid arthritis (ORAL Strategy): a phase 3b/4, double-blind, head-to-head, randomised controlled trial
Hit paper breakdown →
2017412
2 1991396
3 2005209
4 1998147
5 1999143
6 2000133
7
Treatment of refractory, symptomatic, hepatitis C virus related mixed cryoglobulinemia with ribavirin and interferon-alpha.
2000129
8
Clinical evidence for utilization of the A3 adenosine receptor as a target to treat rheumatoid arthritis: data from a phase II clinical trial.
2008122
9 2007103
10 2006102
11 1982100
12 200492
13
Subclinical atherosclerosis in psoriatic arthritis: a case-control study.
200890
14 201081
15 201276
16 197975
17 200668
18 201168
19 200466
20
Hepatitis C virus-related arthritis: characteristics and response to therapy with interferon alpha.
200166

About ITZHAK A. ROSNER

ITZHAK A. ROSNER is a scholar working on Rheumatology, Immunology, Pathology and Forensic Medicine, Epidemiology and Psychiatry and Mental health, having authored 221 papers that have together received 5.8k indexed citations. Recurring topics across this work include Systemic Lupus Erythematosus Research (24 papers), Spondyloarthritis Studies and Treatments (24 papers), Rheumatoid Arthritis Research and Therapies (22 papers), Inflammasome and immune disorders (18 papers), Systemic Sclerosis and Related Diseases (18 papers), Fibromyalgia and Chronic Fatigue Syndrome Research (17 papers), Inflammatory Myopathies and Dermatomyositis (16 papers) and Vasculitis and related conditions (15 papers). The work is most often cited by research in Rheumatology (2.0k citations), Hepatology (337 citations), Immunology (824 citations), Dermatology (328 citations) and Hematology (407 citations). ITZHAK A. ROSNER has collaborated with scholars based in Israel, United States and Italy. Frequent co-authors include Michael Rozenbaum, Gleb Slobodin, Jochanan E. Naschitz, Nina Boulman, Elias Toubi, Daniel Yeshurun, Aharon Kessel, Doron Rimar, Lisa Kaly and Roland W. Moskowitz. Their work appears in journals such as Clinical Rheumatology, Seminars in Arthritis and Rheumatism, Lara D. Veeken, Annals of the Rheumatic Diseases and The Journal of Rheumatology.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact